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Oxidative  stress  attributes  a crucial  role  in  chronic  complication  of  diabetes.  The  aim  of  this
study  was to determine  the  most  effective  part  of  pomegranate  on  oxidative  stress  markers
and antioxidant  enzyme  activities  against  streptozotocin-nicotinamide  (STZ-NA)-induced
diabetic  rats.  Male  Sprague-Dawley  rats  were  randomly  divided  into  six  groups.  Experi-
mental  diabetes  was  induced  by a single  intraperitoneal  injection  (i.p),  15  min  after  the
i.p  administration  of  NA.  Diabetic  rats  showed  signiﬁcant  increase  in  plasma  glucose  level,
and  the  signiﬁcant  decrease  in  plasma  insulin  level.  The  activities  of  antioxidant  enzymes
such  as  total  antioxidant  status  (TAS),  superoxide  dismutase  (SOD),  and  catalase  (CAT)
reduced  while  the  levels  of biomarkers  of  oxidative  stress  such  as  gamma-glutamyle  trans-
ferase (GGT),  and malondialdehyde  (MDA)  increased  in diabetic  control  rats  as  compared
to normal  control  rats. Oral  treatment  with  pomegranate  seed-juice  for  21  days  demon-
strated  signiﬁcant  protective  effects  on  all the  biochemical  parameters  studied.  Besides,
biochemical  ﬁndings  were  supported  by histopathological  study.  These  results  revealedeywords:
ntioxidant
iabetes
xidative Stress
omegranate
that  pomegranate  has  potential  protective  effect  against  oxidative  stress  induced  diabetic
rats.
© 2014  The  Authors.  Published  by  Elsevier  Ireland  Ltd. This  is  an  open  access  article  under
the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).treptozotocin
. IntroductionDiabetes mellitus (DM) is the most crucial disease in the
ndocrine pancreas and cause of death and health problem
n  the modern society [1]. The main characteristic of DM
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214-7500/© 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open
http://creativecommons.org/licenses/by-nc-nd/3.0/).includes high level of blood glucose (hyperglycemia), and
disordered metabolism lipid, carbohydrate, and protein are
caused  by insulin deﬁciency or insulin action or both [2].
Therefore, prolonged exposure to hyperglycemia an imbal-
ance  in glucose metabolism increases the generation of free
radicals,  which reduces abilities of the antioxidant defense
system  to correct and balance for this overproduction, and
places  an over exertion on the endocrine system [3].Free  radicals are involved in the pathogenesis of dia-
betes and the development of diabetic complications [4].
The  elevated levels of blood glucose in diabetes are asso-
ciated with increased lipid peroxidation (LPO), which may
 access article under the CC BY-NC-ND license
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contribute to long-term tissue damage [5]. Various studies
have  demonstrated that DM is associated with oxida-
tive  stress, and resulting to increased production of ROS,
including superoxide radical (O2◦), hydroxyle radical (OH◦)
and  hydrogen peroxide (H2O2) or reduction of antioxidant
defense system [6,7]. There is a lot of evidence that short
term  and long-term hyperglycemia cause an activation of
NADPH  oxidase and formation reactive oxygen intermedi-
ate  (ROI) which are involved in activation of transcription
factor such as NF-B [8]. The endothelium has been demon-
strated as one of the major sources of ROI generation.
These ROIs are able to induce a thrombogenic transfor-
mation of the vessel wall and cause for the endothelial
dysfunction observed in diabetes, hypertension, and hyper-
cholesterolemia [9]. In spite of the presentation of many
hypoglycemic agents, diabetes and its related complica-
tions are still a major medical problem.
Streptozotocin (STZ) has been widely used for induc-
ing diabetes in the experimental animals through its toxic
effects  on pancreatic -cells [10]. STZ is noted to cause pan-
creatic  B-cell damage, while NA is administered to partially
protect insulin-secreting cells against STZ [11]. This model
of  diabetes is useful in studies of different aspects of dia-
betes  [12]. The cytotoxic action of STZ is associated with
the  production of ROS that it causes oxidative stress and
oxidative damage in the cells [13]. Lipid peroxidation (LPO)
is  main marker of oxidative stress. The increased oxidative
stress, as determined by indices of increased LPO, depletion
of  endogenous antioxidant enzymes activities in plasma
that  they are commonly found in the STZ-NA induced dia-
betic  rats [14].
Antioxidants are deﬁned as compounds that can delay,
inhibit, or prevent the oxidation of oxidizable materials
by  scavenging, neutralize free radicals or their actions,
and diminishing oxidative stress [15]. Phytochemicals in
fruits  and vegefs play one of the important roles in preven-
ting  disease that caused by the result of oxidative stress
[16].  The formation of ROS is inhibited by an antioxidant
system that include non-enzymatic antioxidants (i.e. vita-
min  C, A, E, and glutathione), and enzymatic that means
the  enzymes regenerating the reduced forms of antioxi-
dant, and ROS scavenging enzymes such as catalase (CAT),
superoxide dismutase (SOD) [17]. Epidemiological stud-
ies  have demonstrated that many phytonutrient of fruits
might  protect the human body against oxidative stress. The
consumption of natural antioxidant phytochemicals was
noted  to have potential health beneﬁts [18].
Pomegranate fruit has a fascinating history of tradi-
tional use as food, folk medicine, and cultural icon, dating
back  thousands of years [19]. The pomegranate fruit can be
divided  into three anatomical origins: seeds, peel, and arils,
in  which have precious compounds in different parts of the
fruit.  Pomegranate juice is an important product obtained
that  can be got from arils or from whole fruit. The potent
antioxidant capacity of pomegranate and its components
has been reported by numerous scientists using multiple
in  vitro assay systems [20]. This activity is largely due
to  the phenolic content and vitamin C constituents [21].
Pomegranate juice is obtained from arils that was reported
to  be composed of 85% water, 11% total sugars mostly
fructose and glucose, 1.4% pectin, 0.2–1.0% polyphenols,ports 1 (2014) 915–922
and organic acids organic acid like ascorbic acid, citric
acid  and malic acid [22]. Moreover, bioactive compounds
such as phenolic compounds and ﬂavonoids, principally
anthocyanins [23], and minor compound include fatty acid,
-tocopherol [24]. Another part of pomegranate fruit is
seeds  that are a rich source of total lipids. These lipids con-
sist  of 12% to 20% of total seed weight that characterized by
a  high content of polyunsaturated (PUFA) mostly linolenic
(n  − 3), linoleic (n − 2), and other lipids such as punicic acid
(n  − 3), stearic acid, oleic acid, and palmitic acid [25,26].
The seeds also contain sugars, protein, crude ﬁbers, min-
erals,  vitamins, pectin, polyphenols and isoﬂavones [27].
Nowadays, considerable focus has been considered to an
intensive  search for novel type of antioxidants from numer-
ous  plant materials [28]. Phenolic compounds are plant
secondary metabolites commonly found in pomegranate
with attributed pharmacological properties [29]. Among
different kind of phenolic compounds, pomegranate that
the  class of each phenolic has demonstrated to contribute
signiﬁcantly to its unique biological properties [30,31].
The  present study was  undertaken to evaluate whether
the pomegranate has potential to protect antioxidant
status and ameliorate oxidative stress in oxidative stress
generated induced diabetic rats. Histopathological study
was  also carried out to assess the effect of pomegranate
on liver cells against STZ-NA damage in rats.
2. Experimental procedure
2.1.  Animals
Forty-eight adult male Sprague-Dawley rats weight
(250–280 g) were used in the study, and were obtained
from the Animal House at the Faculty of Medicine and
Health Sciences (FPSK). The ethics protocol was approved
by  animal care unit center for the purpose of con-
trol and supervision on experimental animals at UPM
University, Malaysia (APPROVAL NO, UPM/FPSK/PADS/BR-
UUH00502). The animals were housed in standard
polypropylene cages a with 12-h dark/light cycles at ambi-
ent  temperature of 25 ± 2 ◦C. They were quarantined for
one  week, prior to experiment to acclimatize them to labo-
ratory  condition. The animals were handled in accordance
with the Institutional Guidelines for the Care and Use of
Animals  (ACUC) for experimental purposes. The rats were
provided the commercial standard pelleted diet and tap
water  ad libitum. The normal diet (PMI Feeds Inc. Lab Diet
#5001) was a commercial laboratory rodent diet recom-
mended for rats, mice and hamsters, with the following
approximate chemical composition: protein 24%, fat 5.7%,
ﬁber  6.0%, ash 8.0%, and carbohydrate 58%.
2.2. Chemical and drug
STZ  was obtained from Sigma Chemical Co. (St.Sigma–Aldirch (Co. P.O. Box, St. Louis, MO). Glibenclamide
(Glyburide) was prepared from Sigma–Aldich (Co. P.O. Box
G-0639).  All other chemicals and reagents were used of
analytical grade.
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.3. Induction of diabetes in experimental rats
Rats were fasted overnight for 12–h before injection.
hey were induced by a single intraperitoneal (i.p) injection
f  STZ (60 mg/kg body weight (b.w.)). STZ was dissolved
reshly in 0.05 M citrate buffer, (PH 4.5) for this injec-
ion. Nicotinamide was dissolved in normal saline and
dministered (120 mg/kg, i.p) 15 min  before STZ [12]. The
evelopment of hyperglycemia was conﬁrmed by the ele-
ated  glucose levels in blood, determined at 72 h, and then
n  day 7 after injection, which was conﬁrmed by measur-
ng  fasting blood glucose levels in Rats’ blood taken from
ail  vein. The rats with fasting blood glucose level higher
han  126 mg/dl or 7 mmol/L served as diabetic rats and
or  normal control rats remained 4.2 mmol/L [32]. Glucose
easurement was performed with an Accu-Chek gluco-
eter  (Roche, Germany).
.4.  Preparation of pomegranate for treatment
Ripe sweet red pomegranate fruits were used in this
tudy, were imported from Spain. The fruit was washed,
eeled, and the arils were crushed and squeezed with
queezing machine (National Juicer-Blender). The juice is
ltered  for any water insoluble and stored at −18 ◦C. The
eeds  (PS) from the juice preparation were freeze dried at
20 ◦C separately and ground into powder to produce the
econd  and third treatment. The powder was diluted with
istilled  water (DW) with 100 mg  PS in 1 ml  DW and exten-
ively  vortex mixed, and then centrifuged at 3000 rpm for
0  min  at 4 ◦C. Throughout the study, 1 ml  of treatment is
orce  fed by intragastric tube to each rat.
.5. Preparation of Glibenclamide
Sulfonylurea  is anti-diabetic drugs such as Gliben-
lamide (GC), long used in the treatment of non-insulin
ependent diabetes mellitus [33]. Research from the
ntioxidant studies suggests that GC has the potential to
ounteract the reactive oxygen species mediated oxida-
ive  stress [34,35]. Glibenclamide (Sigma–Aldrich, St. Louis,
O,  USA) was dissolved in dimethyl sulfoxide (DMSO)
efore it was administered.
.6.  Experimental design
All  rats randomly were divided into six groups (Table 1),
ach  group consists of eight rats that they were placed in
he  cages (two rats in each cage), and were treated orally
ith  pomegranate seed and juice for a period of 21 days as
ollow:
able 1
ype  of diet and treatment for the rats according to the group.
Group Characteristic of rat Type of
NC Normal control Distille
DC  Diabetic control Distille
PJ  Diabetic treated Pomegr
PS  Diabetic treated Pomegr
PSJ  Diabetic treated Pomegr
GC  Diabetic treated Glibencports 1 (2014) 915–922 917
At  the end of the experimental period, the animals
were fasted overnight and blood samples were collected
from the rats on day 21. The animals were sacriﬁced
under diethyl ether anesthesia, following overnight fas-
ting,  and blood sample was  collected before sacriﬁce via
intra-cardiac puncture using heparin and sodium citrate as
anti-coagulants. The heparinized samples were centrifuge
at  3000 rpm for 15 min  to separate the plasma and eryth-
rocytes. Then, the plasma samples were transferred into
Hitachi  cup for storage at −80 ◦C. Plasma is analyzed by
using  chemical analyzer. Liver tissues were immediately
dissected, washed in ice-cold saline to remove blood. The
liver  was selected because of high generation of free radical
in  their tissues.
2.7.  Biochemical analysis
2.7.1.  Determination of plasma glucose and plasma
insulin
Plasma insulin was determined by using a commercial
kit (Mercodia Rat Insulin ELISA, Catalog No. 10-1250-01)
that provides a method for quantitative determination of
insulin  in rat (Mercodia AB, Sylveniusgatan 8A, Sweden).
Plasma glucose levels were estimated using a commercial
Glucose Colorimetric Assay Kit (Cayman Chemical Com-
pany,  Ann Arbor, MI,  USA).
2.7.2.  Estimation of malondialdehyde (MDA)
Lipid peroxidation is estimated indirectly by the mea-
surement of the secondary products, like malondialdehyde
(MDA) [36]. MDA  level of the plasma was measured by the
following  procedure in which 0.5 ml  of plasma was  shaken
with  2.5 ml  of 20% trichloroacetic acid (TCA) in a 10 ml  cen-
trifuge  falcon tube. 1 ml  of 0.6% thiobarbituric acid (TBA)
was  added to the mixture, shaken, and warmed for 30 min
at  90 ◦C boiling water bath followed by rapid cooling with
cold  water. The mixture was  centrifuged at 3000 rpm for
10  min  then it was  shaken into a 4 ml  of nbutyl-alcohol
layer in a separation tube and MDA  content in the plasma
was  determined by spectrophotometer at the absorbance
532 nm against butanol. The results were expressed as
mol/ml  plasma [37].
2.7.3.  Estimation of gamma-glutamyl transferase (GGT)
In  vitro test for quantitative determination of GGT in
plasma was  used Roche/Hitachi cobas c systems. This
GGT  colorimetric assay is a modiﬁcation of the Szasz
procedure. GGT catalyzes the transfer of the gamma-
glutamyl group from the substrate gamma-glutamyl-3-
carboxy-4-nitroanilide, to glycylglycine, yielding 5-amino-
2-nitrobenzoate. The change in absorbance at 410/480 nm
 treatment Amount of treatment
d water (DW) 1 ml per rat
d water 1 ml per rat
anate juice 1 ml PJ per rat
anate seed powder 100 mg PS + 1 ml  DW per rat
anate seed-juice 1 ml PJ + 100 mg  PS per rat
lamide 5 mg/kg b.w.
ology Re918 A. Aboonabi et al. / Toxic
is due to the formation of 5-amino-2-nitrobenzoate and is
directly  proportional to the GGT activity in the sample [38].
2.7.4.  Estimation of superoxide dismutase (SOD)
Determination of plasma SOD was done by method of
Kakkar  et al. [39]. Brieﬂy, 1.35 ml  of double distilled water,
50  l of sodium pyrophosphate buffer (PH 8.3), 0.1 ml  of
phenazine methosulphate (PMS) and 0.3 ml  of nitroblue
tetrazolium (NBT) were mixed. 0.2 ml  of NADH solution
is  added to it to initiate the reaction. After incubation at
39 ◦C for 90s, the reaction was terminated by adding 1 ml
of  glacial acetic acid. 4 ml  of n-butanol was added and the
mixture  was centrifuged at 4000 rpm for 10 min  and the
absorbance of the upper butanol layer recorded at 560 nm.
For  the comparison, corresponding blank was prepared in
the  same way  except addition of the plasma. One unit of
SOD  activity is deﬁned as that amount of enzyme reaction,
which inhibits the rate of reactions, by 50% in 1 min  under
assay  conditions.
2.7.5. Estimation of catalase (CAT)
This assay employs the quantitative sandwich enzyme
immunoassay technique by ELISA kit. Antibody speciﬁc for
CAT  has been pre-coated onto a micro-plate.
2.7.6. Estimation of total antioxidant status (TAS)
Total antioxidant status was measured in plasma by
Selectera II/E Chemical Analyzer (catalog no. NX 2332;
Randox Laboratories Limited, Antrim, United Kingdom)
applicable for COBAS MIRA (Hoffmann-La Roche, Basel,
Switzerland) and ﬂexor analyzer [40].
2.8. Histopathology study
The  liver samples ﬁxed in the 10% formalin which
were sliced about 1 cm thick, and placed into the cas-
settes. Then, the cassettes were put into tissue processor
machine, which comprise of dehydration with alcohol,
clearing with xylene and wax, following with impregnating
process automatically for overnight (14 h). The cassettes
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were  embedded in molten parafﬁn, which later cooled
down and formed blocks parafﬁn. Each block was trimmed
then  sectioned about 5 m by using a microtome. Then
thin  sections were put in water bath at 45 ◦C few seconds,
ﬁshed out, and set on a microscopic glass slide, proceed
with hematoxylin and eosin (H&E) staining, followed by
mounting with DPX and observed under light microscope
for evaluation.
2.9. Statistical analysis
Statistical  analysis was  performed using SPSS software
for windows, version 21 (SPSS, Inc., Chicago, USA). The
data  was  presented as the mean ± S.E.M. (standard error of
mean).  The statistical signiﬁcant of data analysis has been
assessed  by one-way analysis of variance (ANOVA) and
signiﬁcant difference among treatment groups were evalu-
ated  by Tukey HSD range test. The results were considered
statistically signiﬁcant at p value less than 0.05.
3. Results
Fig. 1 shows plasma insulin levels decreased signif-
icantly (p < 0.05) in the STZ-NA induced diabetic rats,
and  plasma glucose level signiﬁcantly (p < 0.05) increased
compared with the normal control rats. The supplemen-
tation of pomegranate and Glibenclamide increased the
plasma  insulin levels and reduced glucose levels signiﬁ-
cantly (p < 0.05) in the induced diabetic rats. The effect was
more  pronounced in the PSJ supplemented rats than in the
PS  or PJ rats.
Plasma levels of MDA  and GGT have been demonstrated
to be a reliable marker oxidative stress. Fig. 2 shows that
these  parameters were signiﬁcantly (p < 0.05) increased in
diabetic  control in comparison with normal control rats.
However, treatment of diabetic rats with pomegranate
demonstrated a signiﬁcantly (p < 0.05) reversed the con-
centration of MDA  and GGT in the plasma. This reduction
more signiﬁcant (p < 0.05) in PSJ than other treatment
c
d d
c
d
d
0
4
8
12
16
PJ PS J GC
Pl
as
m
a 
in
su
lin
 (µ
U
/m
L)
ucose
sulin
diabetic rats, Each values is mean ± S.E.M. for 8 rats in each group. a–dIn
 control, PS: pomegranate seed, PJ: pomegranate juice, PSJ: pomegranate
A. Aboonabi et al. / Toxicology Re
0
5
10
15
20
m
ic
ro
m
ol
s/
m
L
0
1
2
3
4
5
6
U
ni
t/
L
A
B
a
b
NC DC
a
NC D
c
 PS
Gro
b
c
C PS
G
d
PJ P
ups
MDA
d
PJ
roups
e e
SJ GC
e
PSJ G
GGT
e
C
Fig. 2. Effect of pomegranate on plasma MDA  (A) and GGT (B) plasma in
controls and treatment rats, each value is mean ± S.E.M. for eight rats in
each  group. a–eIn each bar means different signiﬁcantly at p < 0.05. NC: nor-
mal  control, DC: diabetic control, PS: pomegranate seed, PJ: pomegranate
j
g
b
i
a
i
a
p
i
P
o
N
f
(
a
i
d
of  cell types [50]. Thus, ectoplasmic GGT favors the cellular
supply  of GSH, the most important non-protein antioxi-
T
T
Euice, PSJ: pomegranate seed-juice, GC: Glibenclamide.
roups. There was not signiﬁcantly (p < 0.05) difference
etween PSJ and GC groups.
Table  2 demonstrates the activities of enzymatic antiox-
dants namely SOD, CAT, and TAS in the plasma of controls
nd  treatment groups. A signiﬁcant (p < 0.05) reduction
n  the activities of enzymatic antioxidant in STZ-NA
dministered rats was observed. However, treatment with
omegranate increased the level of enzymatic antioxidant
n  the plasma. This increases more signiﬁcant (p < 0.05) in
SJ  than other treatment groups.
Fig. 3A–D illustrates the micrographs of H&E staining
n hepatic tissues in normal control and experimental rats.
ormal  control shows the same normal hepatic structure
ound in other mammals. Each lobule is made up of cells
hepatocytes) that appear a network around a central vein
nd  narrow sinusoids. Pathological changes of STZ-NA-
nduced rats in liver include sinusoidal and central vein
ilation, inﬂammation around central vein, and necrosis
able 2
he  effect of pomegranate on the activities of SOD, CAT, and TAS in controls and t
Parameters Groups
NC DC GC 
SOD (unit/ml) 34.0 ± 0.62a 17.2 ± 0.51b 32.1 ± 0.
CAT (unit/ml) 27.6 ± 0.90a 11.6 ± 1.00b 22.0 ± 1.
TAS (mmol/L) 1.19 ± 0.07a 0.69 ± 0.03 b 0.83 ± 0.
ach value is mean ± S.E.M. for eight rats in each group. a–fin each row means witports 1 (2014) 915–922 919
in  hepatocytes. These changes decreased in diabetic rats
treated  with PSJ.
4.  Discussion
Diabetes arises from destruction of -cell due to the
toxic effect of STZ, which facilitates preferential uptake
into  pancreatic -cells through GLUT2 [41]. There is clear
evidence that free radicals play an essential role in the
mechanism of DNA damage and cytotoxicity by STZ. It
has  been reported that STZ causes radicals generation by
the  xanthine oxidase system of pancreatic cells [42,43],
and  stimulates H2O2 generation. As result, it leads to DNA
fragmentation and necrosis in the pancreatic -cell islets.
Therefore, the rate of insulin synthesis is reduced [44].
Injection of NA, a poly-ADP-ribose synthetase inhibitor,
protects the -cells function by preventing the reduction
in the level of NAD (nicotinamide adenine dinucleotide);
thereby the inhibition of insulin secretion partially reverses
and  it prevents the aggravation of experimental diabetes
following by administration of STZ [45]. This circumstance
contributes a number of characteristics similar to type 2
diabetes  mellitus.
Pomegranate is rich in antioxidants of the polyphe-
nolic class. The antioxidant level in PJ was  discovered to be
higher  than that in other natural fruit juices such as orange,
blueberry, and cranberry, as well as in red wine [46]. These
antioxidants showed various biological activities such as
eliminating free radicals, inhibiting oxidant and microbial
growth [47].
Damages in the pancreatic -cell clinically associated
with the development of diabetes [48]. In this circum-
stance, hyperglycemia leads to the generation of free
radicals, which can exhaust antioxidant defense system,
thereby it causes oxidative damage to cells membranes and
strengthened susceptibility to LPO [49].
Our present exploration showed a signiﬁcant increase
of plasma LPO levels in diabetic rats. Administration of
pomegranate to diabetic rats signiﬁcantly decreased the
levels  of MDA. Pomegranate acts as antioxidant by scav-
enging  free radicals that lead to decrease LPO in diabetic
rats.
The primary role of GGT ectoactivity is to metabolize
extracellular reduced glutathione (GSH), allowing for pre-
cursor  amino acids to be assimilated and reutilized for
intracellular GSH synthesis; in this way, a continuous “GSH
cycling”  across the plasma membrane occurs in a numberdant of the cell [51]. GGT plays a crucial role in antioxidant
defense system [52], and cellular GGT is sensitive marker
reatment.
PS PJ PSJ
95c 20.8 ± 0.61d 25.1 ± 0.42e 28.9 ± 0.8f
21c 13.9 ± 2.63d 19.3 ± 1.13e 21.3 ± 1.15f
02c 0.73 ± 0.11b 0.91 ± 0.01d 1.03 ± 0.03a
h different superscript letter signiﬁcantly at p < 0.05.
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Fig. 3. Liver micrograph sections of normal and diabetic rats treated with PSJ. (A) Normal control shows normal architecture of the hepatocytes around
the  central vein with sinusoidal cards around the central vein and portal tracts (H&E X20). (B) Diabetic section untreated shows dilated sinusoids (black
gniﬁcat
normal harrow)  and dilated central vein (H&E X20). (C) Micrograph with higher ma
the  hepatocytes (H&E X40). (D) Diabetic rats treated with PSJ shows near 
central  vein when compared to diabetic liver (H&E X20).
and enzyme related to the generation of ROS and oxida-
tive  stress. Several previous studies demonstrated that the
inverse  association between serum antioxidants and GGT
was  conﬁrmed [53]. A higher consumption of fruit inversely
predicts GGT level. Our present ﬁnding demonstrated a sig-
niﬁcant  increase in the level of GGT in diabetic groups.
While, PSJ acted as antioxidant by scavenging free radicals,
as  result it can reduce in GGT in diabetic treatment group
as  same effect of Glibenclamide.
Antioxidant  enzymes form the ﬁrst line of defense
against ROS in the cells include SOD, CAT, which play a
key  role in scavenging the toxic intermediate of incomplete
oxidation. A reduction in the activities of these antioxi-
dant enzymes can result in an excess availability of (O2−)
and  H2O2, which in turn production OH ◦, lead to initia-
tion and propagation of LPO. SOD protects cells against ROS
by  scavenging (O2◦¯), which damages the membrane and
biological structures [54]. SOD can catalyze dismutation
of (O2◦¯) into H2O2 then deactivated to H2O by CAT [55].
Thus, SOD can act as a main defense against ROS and pre-
vent  further production of free radicals. The activity of SOD
was  discovered to be lower in diabetic subjects because
of  inactivation by H2O2 or by glycation of the enzyme,
which have been noted to occur in diabetes. CAT is a heme-
protein, which is present almost in all mammalian cells
and  is responsible for the reduction of H2O2 for protecting
cells from highly reactive OH radicals [56]. The reduction in
CAT  activity could also result from inactivation by glycationion shows inﬂammation (red arrows) around central vein and necrosis in
epatocytes, mild sinusoidal dilatation without any inﬂammation around
of  the enzyme. Any combination with antioxidant prop-
erties  might contribute to the partial or total alleviation
of oxidative damage. As a result, removing O2◦ and OH◦
radicals are probably one of the most effective defenses
against diseases [57]. In our exploration showed that treat-
ment  with pomegranate increased the activities of SOD and
CAT  in diabetic rats when compared with diabetic control
rats.  In fact, the reactivation in SOD activity promoted by
pomegranate may  accelerate the dismutation of superox-
ide  to H2O2, which is quickly removed by CAT protecting
tissues of diabetic rats against highly reactive and toxic OH◦
and consequently preventing the LPO.
Multiple defense systems collectively called antioxidant
status that present in the body circumvent damage cell by
oxygen  free radicals (OFR) [58]. This system comprises of
substances that provide stability to free radical by permit-
ting  the pairing of electron. Under normal physiological
situation, a balance exists between antioxidant activity
and  ROS. Many factors disturb this equilibrium such as
diabetes situation, thereby reducing the cell defense capac-
ity  and permitting uncontrolled oxidation of biomolecules
[59]. Present study is observed a decrease in antioxi-
dant activity in diabetic, probably due to the depletion
of antioxidants. We  found that TAS values peaked in PSJ
in  parallel with GC. This suggests that the antioxidant
system can cope efﬁciently with lipoperoxide production
during this critical period, and thus protect against oxida-
tive  stress.
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In the current study, histopathological observation on
he  liver of diabetic untreated rats showed dilation of cen-
ral  vein and sinusoid, inﬂammation and necrosis. These
hanges are provoked by increase production of highly
eactive intermediates of STZ, which are normally detox-
ﬁed  by antioxidant defense system such as SOD and CAT.
owever, they produced in excess can deplete exogenous
ntioxidant and react with liver tissues and destroy hepatic
ells.  The histopathological changes reduced in diabetic
ats  treated with PSJ with high level of antioxidant. More-
ver,  histopathological observation support the notion that
omegranate produced signiﬁcant increase antioxidant
nzyme and protected the hepatic tissue in diabetic rats.
From  our ﬁndings, we infer that pomegranate has ability
o  ameliorate oxidative stress in plasma STZ-NA induced
iabetic rats as evidence by improved glycemic and
educed lipid peroxidation along with improved antiox-
dant  enzymatic status. Moreover, it protect histological
hanges from peroxidation injury through its antioxidant
roperties.
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